Fibroblast growth factor 21 ameliorates psoriasiform inflammation and epidermal hyperplasia through the regulation of

Xueran Guan1, Xianrong Zhu2, Yuxin Lei2

  • 1Department of Biopharmaceuticals, School of Pharmaceutics Sciences, Wenzhou Medical University, Chashan, Wenzhou 325035, Zhejiang Province, China; College of Pharmacy, Chonnam National University, Gwangju 61186, Republic of Korea.

Abstract

Insights

Fibroblast growth factor 21 (FGF21) reduced psoriasis symptoms by modulating inflammation and restoring autophagy. This suggests FGF21 as a potential therapy for psoriasis and other autoimmune diseases.

Area of Science:

  • Dermatology
  • Immunology
  • Metabolic Regulation

Background:

  • Psoriasis is a chronic immune-mediated skin disease with limited long-term treatment efficacy.
  • Fibroblast growth factor 21 (FGF21) has known anti-inflammatory properties but its role in psoriasis is unclear.

Purpose of the Study:

  • To investigate the therapeutic potential of FGF21 in a psoriasis-like mouse model.
  • To elucidate the mechanisms underlying FGF21's effects on skin inflammation and epidermal homeostasis.

Main Methods:

  • Utilized an imiquimod (IMQ)-induced psoriasis-like mouse model for in vivo studies.
  • Conducted histopathological, cytokine, immunohistochemical, and Western blot analyses.
  • Employed in vitro studies with HaCaT and primary human epidermal keratinocytes (NHEKs) to assess FGF21's impact on cellular processes and signaling pathways, including autophagy dependence via chloroquine (CQ) inhibition.

Main Results:

  • FGF21 administration significantly reduced psoriasis-like skin lesions and systemic inflammation in mice.
  • In keratinocytes, FGF21 suppressed inflammation by inhibiting NF-κB activation and restored proliferation-apoptosis balance.
  • FGF21 modulated autophagy, PI3K/AKT, SIRT1, and STAT3 pathways, with its benefits contingent on autophagy restoration.

Conclusions:

  • FGF21 demonstrates therapeutic potential by modulating inflammatory and autophagy-related pathways in psoriasis.
  • FGF21 may serve as a promising therapeutic candidate for psoriasis and other autoimmune inflammatory conditions.

Related Concept Videos

Introduction to Fibroblasts01:09

Introduction to Fibroblasts

Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...